參考文獻 |
1. Vanneman M, Dranoff G. “Combining immunotherapy and targeted therapies in cancer treatment”. Nature reviews cancer.2012; 12(4): 237-251.
2. Couzin-Frankel J. “Cancer immunotherapy”. Science.2013; 342(6165): 1432-1433.
3. http://www.j-immunother.com/english/immuno-Cell/kind.html.
4. Dhar S, Gu FX, Langer R, Farokhzad OC, Lippard SJ. “Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt (IV) prodrug-PLGA–PEG nanoparticles”. Proceedings of the National Academy of Sciences.2008; 105(45): 17356-17361.
5. Shi J. “A New Strategy of Drug Delivery: Electric Field Distribution in Brain Tumor Due to Electroporation”. The Journal of Purdue Undergraduate Research.2014; 4(1): 9.
6. Aihara H, Miyazaki J-i. “Gene transfer into muscle by electroporation in vivo”. Nature biotechnology.1998; 16(9): 867-870.
7. Chen X. Cellular stress induced by microbubble-mediated sonoporation: The University of Hong Kong (Pokfulam, Hong Kong); 2013.
8. Bao S, Thrall BD, Miller DL. “Transfection of a reporter plasmid into cultured cells by sonoporation in vitro”. Ultrasound in medicine & biology.1997; 23(6): 953-959.
9. Lu Z-Z, Wu J, Sun T-M, Ji J, Yan L-F, Wang J. “Biodegradable polycation and plasmid DNA multilayer film for prolonged gene delivery to mouse osteoblasts”. Biomaterials.2008; 29(6): 733-741.
10. RAO MG, BHARATHI P, AKILA R. “A COMPREHENSIVE REVIEW ON BIOPOLYMERS”.2014;4(2): 61-68.
11. Madison LL, Huisman GW. “Metabolic engineering of poly (3-hydroxyalkanoates): from DNA to plastic”. Microbiology and molecular biology reviews.1999; 63(1): 21-53.
12. 傅佑璋. “聚乳酸(PLA)及乳酸/羥基乙酸共聚合物(PLGA)於抗癌藥物傳輸系統之研究; The study of polylactide and Polylactide-co-glycolide in the anti-cancer drugs delivery stem”.2001.
13. Kocbek P, Obermajer N, Cegnar M, Kos J, Kristl J. “Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody”. Journal of Controlled Release.2007; 120(1): 18-26.
14. Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX, et al. “Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery”. Biomaterials.2007; 28(5): 869-876.
15. Novikova LN, Novikov LN, Kellerth J-O. “Biopolymers and biodegradable smart implants for tissue regeneration after spinal cord injury”. Current opinion in neurology.2003; 16(6): 711-715.
16. Boyce ST, Greenhalgh DG, Kagan RJ, Housinger T, Sorrell JM, Childress CP, et al. “Skin anatomy and antigen expression after burn wound closure with composite grafts of cultured skin cells and biopolymers”. Plastic and reconstructive surgery.1993; 91(4): 632-641.
17. Di Martino A, Sittinger M, Risbud MV. “Chitosan: a versatile biopolymer for orthopaedic tissue-engineering”. Biomaterials.2005; 26(30): 5983-5990.
18. Siegel SJ, Kahn JB, Metzger K, Winey KI, Werner K, Dan N. “Effect of drug type on the degradation rate of PLGA matrices”. European Journal of Pharmaceutics and Biopharmaceutics.2006; 64(3): 287-293.
19. Zolnik BS, Burgess DJ. “Effect of acidic pH on PLGA microsphere degradation and release”. Journal of Controlled Release.2007; 122(3): 338-344.
20. Makadia HK, Siegel SJ. “Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier”. Polymers.2011; 3(3): 1377-1397.
21. Anderson JM, Shive MS. “Biodegradation and biocompatibility of PLA and PLGA microspheres”. Advanced drug delivery reviews.2012; 64: 72-82.
22. Houchin M, Topp E. “Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms”. Journal of pharmaceutical sciences.2008; 97(7): 2395-2404.
23. Klose D, Siepmann F, Elkharraz K, Siepmann J. “PLGA-based drug delivery systems: importance of the type of drug and device geometry”. International journal of pharmaceutics.2008; 354(1): 95-103.
24. Xin X, Hussain M, Mao JJ. “Continuing differentiation of human mesenchymal stem cells and induced chondrogenic and osteogenic lineages in electrospun PLGA nanofiber scaffold”. Biomaterials.2007; 28(2): 316-325.
25. Franco RA, Nguyen TH, Lee B-T. “Preparation and characterization of electrospun PCL/PLGA membranes and chitosan/gelatin hydrogels for skin bioengineering applications”. Journal of Materials Science: Materials in Medicine.2011; 22(10): 2207-2218.
26. Willot G, Gomez F, Vast P, Andries V, Martines M, Messaddeq Y, et al. “Preparation of zinc sodium polyphosphates glasses from coacervates precursors. Characterisation of the obtained glasses, and their applications”. Comptes Rendus Chimie.2002; 5(12): 899-906.
27. Luzzi LA, Gerraughty RJ. “Effects of selected variables on the extractability of oils from coacervate capsules”. Journal of pharmaceutical sciences.1964; 53(4): 429-431.
28. http://www.sigmaaldrich.com/technical-documents/articles/material-
matters/polyester-based-nanoparticle-formation.html.
29. Alex R, Bodmeier R. “Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment”. Journal of Microencapsulation.1990; 7(3): 347-355.
30. O′Donnell PB, McGinity JW. “Preparation of microspheres by the solvent evaporation technique”. Advanced drug delivery reviews.1997; 28(1): 25-42.
31. Uchida T, Yoshida K, Goto S. “Preparation and characterization of polylactic acid microspheres containing water-soluble dyes using a novel w/o/w emulsion solvent evaporation method”. Journal of microencapsulation.1996; 13(2): 219-228.
32. Liu R, Ma G-H, Wan Y-H, Su Z-G. “Influence of process parameters on the size distribution of PLA microcapsules prepared by combining membrane emulsification technique and double emulsion-solvent evaporation method”. Colloids and Surfaces B: Biointerfaces.2005; 45(3): 144-153.
33. Saxena V, Sadoqi M, Shao J. “Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release”. International journal of pharmaceutics.2004; 278(2): 293-301.
34. Tewes F, Munnier E, Antoon B, Ngaboni Okassa L, Cohen-Jonathan S, Marchais H, et al. “Comparative study of doxorubicin-loaded poly (lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods”. European journal of pharmaceutics and biopharmaceutics.2007; 66(3): 488-492.
35. Niwa T, Takeuchi H, Hino T, Nohara M, Kawashima Y. “Biodegradable submicron carriers for peptide drugs: preparation of DL-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate by a novel emulsion-phase separation method in an oil system”. International journal of pharmaceutics.1995; 121(1): 45-54.
36. Dillen K, Vandervoort J, Van den Mooter G, Ludwig A. “Evaluation of ciprofloxacin-loaded Eudragit< sup>® RS100 or RL100/PLGA nanoparticles”. International journal of pharmaceutics.2006; 314(1): 72-82.
37. Budhian A, Siegel SJ, Winey KI. “Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content”. International journal of pharmaceutics.2007; 336(2): 367-375.
38. Galindo-Rodriguez S, Allemann E, Fessi H, Doelker E. “Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods”. Pharmaceutical research.2004; 21(8): 1428-1439.
39. Shung KK. “Diagnostic ultrasound: past, present, and future”. Journal of Medical and Biological Engineering.2011; 31(6): 371-374.
40. Zhao L, Kampmann M, Prior SJ, Sorkin MJ, Braganza M, McEvoy S, et al. “Freehand 3D Ultrasound to Measure Thrombus Volume in Patients with Acute Deep-Vein Thrombosis”. Journal for Vascular Ultrasound.2014; 38(1): 23-28.
41. Barry C, Allott C, John N, Mellor P, Arundel P, Thomson D, et al. “Three-dimensional freehand ultrasound: image reconstruction and volume analysis”. Ultrasound in medicine & biology.1997; 23(8): 1209-1224.
42. Liang H, Tang J, Halliwell M. “Sonoporation, drug delivery, and gene therapy”. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine.2010; 224(2): 343-361.
43. Suslick KS. “The chemical effects of ultrasound”. Scientific American.1989; 260(2): 80-86.
44. Tomita Y, Matsuura T, Kodama T. “Temporal effect of inertial cavitation with and without microbubbles on surface deformation of agarose S gel in the presence of 1-MHz focused ultrasound”. Ultrasonics.2014.
45. Saliba Y, Mougenot N, Jacquet A, Atassi F, Hatem S, Farès N, et al. “A new method of ultrasonic nonviral gene delivery to the adult myocardium”. Journal of molecular and cellular cardiology.2012; 53(6): 801-808.
46. Yasuda K, Umemura S-i, Takeda K. “Concentration and fractionation of small particles in liquid by ultrasound”. Japanese journal of applied physics.1995; 34(5S): 2715.
47. Yasuda K, Umemura Si, Takeda K. “Particle separation using acoustic radiation force and elecrostatic force”. The Journal of the Acoustical Society of America.1996; 99(4): 1965-1970.
48. Dayton P, Klibanov A, Brandenburger G, Ferrara K. “Acoustic radiation force< i> in vivo: a mechanism to assist targeting of microbubbles”. Ultrasound in medicine & biology.1999; 25(8): 1195-1201.
49. Kobayashi D, Hayashida Y, Sano K, Terasaka K. “Agglomeration and rapid ascent of microbubbles by ultrasonic irradiation”. Ultrasonics sonochemistry.2011; 18(5): 1193-1196.
50. Spengler J, Coakley W, Christensen K. “Microstreaming effects on particle concentration in an ultrasonic standing wave”. AIChE journal.2003; 49(11): 2773-2782.
51. Petersson F, Nilsson A, Holm C, Jönsson H, Laurell T. “Continuous separation of lipid particles from erythrocytes by means of laminar flow and acoustic standing wave forces”. Lab on a Chip.2005; 5(1): 20-22.
52. Bazou D, Kearney R, Mansergh F, Bourdon C, Farrar J, Wride M. “Gene expression analysis of mouse embryonic stem cells following levitation in an ultrasound standing wave trap”. Ultrasound in medicine & biology.2011; 37(2): 321-330.
53. Lee Y-H, Peng C-A. “Nonviral transfection of suspension cells in ultrasound standing wave fields”. Ultrasound in medicine & biology.2007; 33(5): 734-742.
54. Mao S, Xu J, Cai C, Germershaus O, Schaper A, Kissel T. “Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres”. International journal of pharmaceutics.2007; 334(1): 137-148.
55. Allison SD. “Analysis of initial burst in PLGA microparticles”.2008.
56. Cleland JL. “Solvent evaporation processes for the production of controlled release biodegradable microsphere formulations for therapeutics and vaccines”. Biotechnology progress.1998; 14(1): 102-107.
57. Wang J, Wang BM, Schwendeman SP. “Characterization of the initial burst release of a model peptide from poly (D, L-lactide-co-glycolide) microspheres”. Journal of controlled release.2002; 82(2): 289-307.
58. Batycky RP, Hanes J, Langer R, Edwards DA. “A theoretical model of erosion and macromolecular drug release from biodegrading microspheres”. Journal of pharmaceutical sciences.1997; 86(12): 1464-1477.
59. http://oncosec.com/tag/electroporation/.
60. Benjaminsen RV, Mattebjerg MA, Henriksen JR, Moghimi SM, Andresen TL. “The possible “proton sponge” effect of polyethylenimine (PEI) does not include change in lysosomal pH”. Molecular Therapy.2012; 21(1): 149-157.
61. http://www.mdpi.com/2073-4360/2076/2076/1727/htm. |